ESC 23: OCTIVUS: OCT Vs IVUS-Guided Percutaneous Coronary Intervention

Published: 28 Aug 2023

  • Views:

    Views Icon 225
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

ESC 2023 — We are joined onsite by Dr Duk-Woo Park and Dr Do-Yoon Kang (Asan Medical Center, Seoul, KR) to discuss the findings from the OCTIVUS study (NCT03394079). 


The OCTIVUS study (Seung-Jung Park, CardioVascular Research Foundation, Korea) aims to compare the clinical safety and efficacy of optimal coherence tomography (OCT) guided and intravascular ultrasound (IVUS) guided strategies in coronary artery disease (CAD) patients receiving percutaneous coronary interventions (PCI) with drug-eluting stents (DES) or drug-coated balloons (DCB). 2008 patients were enrolled in the trial, and were randomized to receive either the experimental OCT-guided PCI, or IVUS-Guided PCI.


Results show that OCT-guided PCI was non-inferior to IVUS-guided PCI in regard to target-vessel failure at one year.



  1. What is the unmet need you are trying to address with this study?
  2. What was the patient population and study design?
  3. What are the key findings?
  4. How should these findings impact clinical practice?
  5. What questions have arisen from this trial?


Recorded on-site at ESC Congress 2023, Amsterdam. 

For more content from ESC Congress 2023 head to the Hot Line & Late-breaking Science Video Collection.

Editors: Mirjam Boros and Jordan Rance
Video Specialists: Dan Brent, Tom Green, Mike Knight, Oliver Miles


You must be to comment. If you are not registered, you can register here.